ZNF-Mediated Resistance to Imatinib Mesylate in Gastrointestinal Stromal Tumor

Although imatinib mesylate (IM) has transformed the treatment of gastrointestinal stromal tumors (GIST), many patients experience primary/secondary drug resistance. In a previous study, we identified a gene signature, consisting mainly of Kruppel-associated box (KRAB) domain containing zinc finger (...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Rink, Lori, Ochs, Michael F., Zhou, Yan, von Mehren, Margaret, Godwin, Andrew K.
Формат: Artigo
Язык:Inglês
Опубликовано: Public Library of Science 2013
Предметы:
Research Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC3556080/
https://ncbi.nlm.nih.gov/pubmed/23372733
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0054477
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы